Crypto Bill Fails: What It Means for Stablecoin Yield
Three Fed cuts. That was supposed to be the fix.
The VanEck Mortgage REIT Income ETF — ticker MORT — owns a basket of 26 mortgage REITs and trades near $9.95 with a headline yield that depends on which number you read: 13.19% on VanEck’s 30-day SEC yield, closer to 14.9% on a trailing twelve-month basis. Either way, it’s the kind of number that makes an income investor stop scrolling. It’s also the kind of number this site has learned not to trust without checking the book value column first.
We’ve done that check twice already this year, one ticker at a time. AGNC’s Q1 2026 economic return came in at -1.6% — the dividend got paid, but book value fell further, so shareholders finished the quarter behind. Annaly’s Q1 was better, +1.5%, but still fragile. Both posts ended on the same unresolved question: does the mREIT trade actually work over a full cycle, or does the yield just look real until the next spread-widening quarter erases it?
MORT is the sector-wide version of that same question. It doesn’t bet on one balance sheet — Annaly is 19.4% of the fund, AGNC another 15.4%, then Rithm Capital, Starwood Property Trust, and Dynex Capital rounding out the top five. If the Fed’s three 2025 cuts were going to fix mREIT economics broadly and not just at one company, Q2 2026 earnings from the fund’s two biggest holdings are where that shows up first.
Quick Verdict
Factor Details Price ~$9.95 (VanEck NAV, Aug 14, 2026) Yield 13.19% SEC 30-day yield / ~14.9% trailing twelve-month Expense ratio 0.43% Top holdings Annaly Capital (~19.4%), AGNC Investment (~15.4%), Rithm Capital (~7.5%) Total holdings 26 mortgage REITs 5-year price return -1.25% annualized (roughly -6% cumulative) Distribution trend $1.5278/share (2022 peak) → $1.2261 (2024 trough) → $1.3412 (2025, +9.4%) Passivity score 5/10 — a single ticker for sector exposure, but the yield still requires tracking book value at the underlying holdings Best for: Investors who want diversified mREIT income without picking individual balance sheets, and who track total return, not just the distribution
Skip if: You’re buying the 14% headline as durable income without understanding that it’s built from the same spread-risk mechanics as every ticker underneath it
MORT tracks the MVIS US Mortgage REITs Index, holding roughly 26 companies that borrow short-term and invest in mortgages or mortgage-backed securities, earning the spread between the two. Some, like AGNC, run almost entirely government-guaranteed agency MBS. Others, like Rithm and Starwood, mix in commercial mortgages, non-agency credit, and origination businesses. The fund charges a 0.43% expense ratio and rebalances the way any single-strategy sector ETF does — by market cap within the index rules, not by picking winners.
That structure is the whole pitch. Buying MORT instead of AGNC alone means you’re not exposed to one company’s leverage decisions or one management team’s hedge book. You’re exposed to the sector’s decisions, averaged. Which is exactly why Q2 2026 earnings from the two largest names in the fund matter more than any one ticker’s results would on their own — together, Annaly and AGNC are nearly 35 cents of every dollar in MORT.
Here’s the number that the 14% yield conveniently sits next to without explaining: MORT’s price has returned -1.25% annualized over five years, according to VanEck’s own performance data. Compounded, that’s a cumulative loss of roughly 6% in the share price alone — before counting what taxes and reinvestment timing do to the distributions collected along the way.
That’s not a random five years, either. It spans the 2022 rate-hike shock, the higher-for-longer stretch of 2023-2024, and the start of the 2025 cutting cycle. mREITs got hit from every direction the Fed can hit a leveraged spread business: rising short rates compress net interest margin, and volatility widens the MBS spreads that determine book value. MORT’s price chart is the aggregate scar tissue from all of it.
The distribution history tells the same story from a different angle. MORT paid $1.5278 per share in 2022. That fell to $1.4393 in 2023, then to $1.2261 in 2024 — the trough, not 2025 like you might expect if the pain were still building. In 2025, distributions rose to $1.3412, a 9.4% increase off the low. The timing lines up: the Fed’s three cuts landed in September, October, and December of 2025, right as that year’s distribution total turned upward for the first time since 2022.
One year of higher distributions after two years of cuts isn’t proof of a trend. It’s a data point. The Q2 2026 earnings from the fund’s biggest holdings are what tell you whether that data point is the start of something or a one-year blip.
AGNC’s Q1 2026 economic return was -1.6% — book value fell from $8.88 to $8.38 as MBS spreads widened against the company’s 7.4x leverage, more than offsetting the dividend collected that quarter. We flagged it as the mechanism, not a one-off failure: leveraged agency portfolios lose book value when spreads widen, full stop, regardless of what the monthly distribution does.
AGNC’s Q2 2026 results, published July 20, reversed it. Tangible net book value per share rose to $8.58, up 2.4% from $8.38 the prior quarter — and up roughly 9.9% from $7.81 a year earlier. Spreads that widened in Q1 partially normalized in Q2, and a highly leveraged portfolio that amplified the loss on the way down amplified the recovery on the way back up.
That’s the pattern this site described in April, playing out on schedule: spread widens, book value falls, spread normalizes, book value recovers. Q2 2026 is the recovery leg. It doesn’t erase AGNC’s longer dividend-cut history — the monthly payout is still 40% below its 2015 level — but it does mean the Fed cuts and the subsequent spread normalization did what the sector needed them to do, at least for one quarter.
If AGNC’s Q2 was a recovery, Annaly’s Q2 2026 results were closer to vindication. Economic return came in at 5.5% for the quarter — 6.9% for the first half of 2026 combined. Book value rose to $20.15 per share, up 1.7% from $19.82 at the end of Q1. Earnings available for distribution hit $0.79 per share against a dividend that management raised to $0.75, the ninth straight quarter EAD has covered the payout.
A dividend raise. Not a cut, not a hold — an increase, on the back of a quarter that beat the distribution by six cents a share. That’s the opposite of what a skeptical read of mREIT economics would have predicted a year ago, and it’s the strongest single data point in favor of “the trade is working” that this site has covered on any mREIT name.
Annaly’s economic leverage also ticked down, from 5.7x to 5.6x, while GAAP leverage rose slightly to 7.4x from 7.3x — the company leaning a bit more into its diversified Residential Credit and MSR sleeves rather than pure agency exposure, the same structural advantage we noted in April as the reason Annaly’s Q1 outperformed AGNC’s.
| Instrument | Approx Yield | Structure | Q2 2026 Signal |
|---|---|---|---|
| MORT (diversified mREIT ETF) | ~13-15% | 26 mREITs, agency + credit mix | Top 2 holdings both improved book value/economic return |
| AGNC (single mREIT) | ~13% | 7.4x levered, pure agency | +2.4% QoQ book value, reversing Q1 loss |
| NLY (single mREIT) | ~12% | 5.6x levered, diversified | +5.5% economic return, dividend raised |
| ARCC / BDCs | ~10.6% | Floating-rate direct lending | Credit risk, not spread risk |
| PFF preferred ETFs | ~6.5% | Fixed-rate, call-capped | Rate-driven, not spread-driven |
| T-bills / HYSA | ~4% | None | Stable, no cycle risk |
MORT’s argument over owning AGNC or NLY individually isn’t a higher yield — it’s not paying either one. It’s that a bad balance-sheet decision at one company, or a management team slow to hedge, gets diluted across 24 other holdings. The tradeoff is that MORT also owns whatever the weaker names in that basket are doing, and this site hasn’t independently checked Rithm, Starwood, or Dynex’s Q2 numbers the way we have Annaly and AGNC’s. The concentration in the top two holdings means their results carry the fund either way.
Investors who want mREIT income exposure but don’t want to underwrite individual leverage decisions. Owning MORT instead of AGNC directly means one bad hedge call at one company costs you a percentage point or two of the fund, not the whole position. For investors who’ve read the total-return math on dividend investing and still want sector exposure, the diversification is a real risk reduction, not just a marketing line.
Tax-advantaged account holders comfortable with ordinary-income taxation. Like the individual mREITs underneath it, MORT’s distributions are typically taxed as ordinary income. In an IRA or 401(k), a 13-15% yield compounds without annual tax drag. In a taxable account at a high bracket, the after-tax number is meaningfully lower than the headline.
Investors who track the underlying holdings’ quarterly earnings, not just the fund’s distribution. The whole thesis behind this post — that Q2 2026 shows real recovery — required reading AGNC’s and Annaly’s actual earnings releases, not just noting that MORT’s distribution ticked up. If you’re not willing to do that quarterly, you’re buying a yield you can’t actually evaluate.
Anyone who needs the 5-year price chart to not matter. A -1.25% annualized price return over five years is the honest starting point. The yield has to do a lot of work to make total return positive over a full cycle, and two good quarters in 2026 don’t undo that history.
Income investors who haven’t priced in another rate or spread shock. The Fed’s three 2025 cuts and Q2 2026’s book value recovery are the tailwind case. A renewed spread-widening event — another tariff shock, a credit scare, a hawkish surprise — hits MORT’s underlying holdings the same way it hit AGNC in Q1. That macro risk hasn’t gone away just because two quarters went well.
Anyone already concentrated in rate-sensitive income. If your portfolio holds preferred stock ETFs, long-duration bonds, or BDCs paying similarly high yields, adding MORT doesn’t diversify that exposure — it stacks another leveraged, spread-sensitive sleeve on top of ones you may already own.
Three Fed cuts didn’t fix mREIT economics by decree — they changed the spread environment enough that Q2 2026 earnings from MORT’s two biggest holdings actually improved instead of eroding further. AGNC’s book value rose 2.4% quarter over quarter, reversing Q1’s loss. Annaly’s economic return hit 5.5% and its dividend went up. That’s real evidence the sector-wide trade is working right now, not just at one hand-picked ticker.
It’s also two quarters, not two years. MORT’s -1.25% annualized five-year price return and its distribution history — a 2022 peak that took until 2025 to even partially recover from — are the reminder that this sector runs in cycles most income investors don’t hold through comfortably. The 13-15% yield is real income, built from real spread on real mortgage assets. Whether it’s finally “safe” depends on whether Q2 2026 was the start of a recovery or the good quarter every mREIT cycle produces before the next spread-widening event shows up.
MORT fund data from VanEck’s official MORT product page and StockAnalysis.com, as of August 13-14, 2026. AGNC Q2 2026 figures from the AGNC Investment Corp. Q2 2026 earnings release, July 20, 2026. Annaly Q2 2026 figures from the Annaly Capital Management Q2 2026 earnings release, July 21, 2026. Fed rate decisions from the Federal Reserve’s December 2025 press release and prior FOMC statements. This is not financial or investment advice. Verify current price, yield, and holdings data before making investment decisions.